| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
|
Lancet
|
2015
|
7.99
|
|
2
|
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.
|
Lancet
|
2015
|
6.13
|
|
3
|
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study.
|
Lancet Neurol
|
2009
|
3.36
|
|
4
|
Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome.
|
Arch Intern Med
|
2005
|
2.22
|
|
5
|
Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease.
|
Isr Med Assoc J
|
2004
|
2.02
|
|
6
|
Long-term changes in serum cholesterol level does not influence the progression of coronary calcification.
|
Int J Cardiol
|
2010
|
1.99
|
|
7
|
Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease.
|
Neurology
|
2006
|
1.65
|
|
8
|
Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004).
|
Neuroepidemiology
|
2009
|
1.64
|
|
9
|
Perceptual, social, and behavioral factors associated with delays in seeking medical care in patients with symptoms of acute stroke.
|
Stroke
|
2006
|
1.63
|
|
10
|
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency.
|
Blood
|
2008
|
1.57
|
|
11
|
Ischemic stroke on awakening: patients' characteristics, outcomes and potential for reperfusion therapy.
|
Neuroepidemiology
|
2012
|
1.55
|
|
12
|
Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome.
|
Am J Cardiol
|
2007
|
1.50
|
|
13
|
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate.
|
Arch Intern Med
|
2006
|
1.46
|
|
14
|
Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death.
|
Circulation
|
2008
|
1.45
|
|
15
|
Effectiveness of establishing a dedicated acute stroke unit in routine clinical practice in Israel.
|
Isr Med Assoc J
|
2005
|
1.41
|
|
16
|
Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
|
Isr Med Assoc J
|
2004
|
1.39
|
|
17
|
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
|
Stroke
|
2012
|
1.28
|
|
18
|
Chronic kidney disease and clinical outcome in patients with acute stroke.
|
Stroke
|
2009
|
1.25
|
|
19
|
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
|
Am J Cardiol
|
2006
|
1.17
|
|
20
|
Two-dimensional intraventricular flow mapping by digital processing conventional color-Doppler echocardiography images.
|
IEEE Trans Med Imaging
|
2010
|
1.17
|
|
21
|
Spiral computed tomography evidence of close correlation between coronary and thoracic aorta calcifications.
|
Atherosclerosis
|
2004
|
1.11
|
|
22
|
A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke.
|
J Stroke Cerebrovasc Dis
|
2008
|
1.11
|
|
23
|
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients.
|
Eur Heart J
|
2005
|
1.09
|
|
24
|
Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.09
|
|
25
|
Salvaging brain: new concepts in the management of acute stroke.
|
Isr Med Assoc J
|
2004
|
1.08
|
|
26
|
Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.
|
Stroke
|
2009
|
1.07
|
|
27
|
Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome.
|
Cerebrovasc Dis
|
2010
|
1.04
|
|
28
|
Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS).
|
Stroke
|
2009
|
1.00
|
|
29
|
Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease.
|
Am Heart J
|
2007
|
0.99
|
|
30
|
Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study.
|
J Am Coll Cardiol
|
2002
|
0.99
|
|
31
|
Hospital disposition after stroke in a national survey of acute cerebrovascular diseases in Israel.
|
Arch Phys Med Rehabil
|
2008
|
0.98
|
|
32
|
Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease.
|
Cogn Behav Neurol
|
2007
|
0.94
|
|
33
|
Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data.
|
PLoS One
|
2012
|
0.93
|
|
34
|
Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials.
|
Lancet Neurol
|
2004
|
0.93
|
|
35
|
Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
|
Am J Cardiol
|
2009
|
0.92
|
|
36
|
Body height is associated with decreased long-term stroke but not coronary heart disease mortality?
|
Stroke
|
2002
|
0.92
|
|
37
|
Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes.
|
Eur J Cardiovasc Prev Rehabil
|
2006
|
0.92
|
|
38
|
Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes.
|
Atherosclerosis
|
2006
|
0.92
|
|
39
|
Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale.
|
Arch Neurol
|
2004
|
0.90
|
|
40
|
Transcutaneous detection of aortic arch atheromas by suprasternal harmonic imaging.
|
J Am Coll Cardiol
|
2002
|
0.89
|
|
41
|
Diabetes, hyperglycemia and the management of cerebrovascular disease.
|
Curr Opin Neurol
|
2011
|
0.89
|
|
42
|
Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry.
|
Arch Intern Med
|
2002
|
0.88
|
|
43
|
Centenarian stroke treated with tissue-type plasminogen activator.
|
Cerebrovasc Dis
|
2002
|
0.88
|
|
44
|
Similarity of the swine vasculature to the human carotid bifurcation: analysis of arterial diameters.
|
J Vasc Interv Radiol
|
2008
|
0.87
|
|
45
|
Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.
|
Cerebrovasc Dis
|
2012
|
0.87
|
|
46
|
Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
|
Am J Cardiol
|
2008
|
0.87
|
|
47
|
Quantitative detection of thrombin activity in an ischemic stroke model.
|
J Mol Neurosci
|
2013
|
0.86
|
|
48
|
Thrombin regulation of synaptic plasticity: implications for physiology and pathology.
|
Exp Neurol
|
2013
|
0.86
|
|
49
|
Poor neighborhood socioeconomic status and risk of ischemic stroke after myocardial infarction.
|
Epidemiology
|
2011
|
0.86
|
|
50
|
The application of MRI for depiction of subtle blood brain barrier disruption in stroke.
|
Int J Biol Sci
|
2010
|
0.86
|
|
51
|
Ischemic stroke due to acute basilar artery occlusion: proportion and outcomes.
|
Isr Med Assoc J
|
2010
|
0.85
|
|
52
|
Left ventricular diastolic function in trained male weight lifters at rest and during isometric exercise.
|
Am J Cardiol
|
2008
|
0.85
|
|
53
|
Hemodynamic evaluation of embolic trajectory in an arterial bifurcation: an in-vitro experimental model.
|
Stroke
|
2005
|
0.84
|
|
54
|
Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage.
|
Int J Stroke
|
2010
|
0.84
|
|
55
|
Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease?
|
J Neural Transm (Vienna)
|
2010
|
0.84
|
|
56
|
Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.
|
Clin Neuropharmacol
|
2006
|
0.84
|
|
57
|
Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
|
Cardiology
|
2006
|
0.83
|
|
58
|
Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial.
|
Arch Intern Med
|
2009
|
0.83
|
|
59
|
Capturing the scope of stroke: silent, whispering, and overt.
|
Arch Neurol
|
2009
|
0.82
|
|
60
|
The anticoagulant activated protein C (aPC) promotes metaplasticity in the hippocampus through an EPCR-PAR1-S1P1 receptors dependent mechanism.
|
Hippocampus
|
2014
|
0.82
|
|
61
|
Apolipoproteins B and AI and the risk of ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease.
|
J Neurol Sci
|
2008
|
0.82
|
|
62
|
Gender differences in characteristics, management and outcome at discharge and three months after stroke in a national acute stroke registry.
|
Int J Cardiol
|
2013
|
0.81
|
|
63
|
Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
|
Cardiovasc Diabetol
|
2008
|
0.81
|
|
64
|
Treating seizures and epilepsy with anticoagulants?
|
Front Cell Neurosci
|
2013
|
0.81
|
|
65
|
The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease.
|
J Geriatr Psychiatry Neurol
|
2012
|
0.81
|
|
66
|
Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke.
|
Am Heart J
|
2008
|
0.81
|
|
67
|
Serum calcium levels and long-term mortality in patients with acute stroke.
|
Cerebrovasc Dis
|
2010
|
0.81
|
|
68
|
Extent of hypoattenuation on CT angiography source images in basilar artery occlusion: prognostic value in the Basilar Artery International Cooperation Study.
|
Stroke
|
2011
|
0.81
|
|
69
|
Feasibility, safety and efficacy of an early aerobic rehabilitation program for patients after minor ischemic stroke: A pilot randomized controlled trial.
|
NeuroRehabilitation
|
2011
|
0.80
|
|
70
|
Usefulness of helical computed tomography in detection of mitral annular calcification as a marker of coronary artery disease.
|
Int J Cardiol
|
2005
|
0.80
|
|
71
|
Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
|
Blood Press
|
2014
|
0.80
|
|
72
|
Burden and outcome of prevalent ischemic brain disease in a national acute stroke registry.
|
Stroke
|
2013
|
0.79
|
|
73
|
Trends in admission blood pressure and stroke outcome in patients with acute stroke and transient ischemic attack in a National Acute Stroke registry.
|
J Hypertens
|
2016
|
0.79
|
|
74
|
Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study.
|
J Stroke Cerebrovasc Dis
|
2010
|
0.79
|
|
75
|
Chlamydia pneumoniae and future risk in patients with coronary heart disease.
|
Int J Cardiol
|
2004
|
0.78
|
|
76
|
Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease.
|
Clin Cardiol
|
2005
|
0.78
|
|
77
|
C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
|
Am Heart J
|
2007
|
0.78
|
|
78
|
Correlates of well-being among caregivers of long-term community-dwelling stroke survivors.
|
Int J Rehabil Res
|
2016
|
0.77
|
|
79
|
Coronary and aortic calcifications inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--Israeli spiral computed tomography substudy.
|
Isr Med Assoc J
|
2007
|
0.77
|
|
80
|
Body height and late-life cognition among patients with atherothrombotic disease.
|
Alzheimer Dis Assoc Disord
|
2013
|
0.77
|
|
81
|
White blood cell count and the incidence of ischemic stroke in coronary heart disease patients.
|
Am J Med
|
2005
|
0.77
|
|
82
|
[Guidelines for the management of stroke--2007 prevention of ischemic stroke--general approach and medical treatment].
|
Harefuah
|
2007
|
0.77
|
|
83
|
Acute basilar artery occlusion in the Basilar Artery International Cooperation Study: does gender matter?
|
Stroke
|
2010
|
0.77
|
|
84
|
Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: insights from two consecutive national surveys.
|
Int J Cardiol
|
2010
|
0.77
|
|
85
|
Perceived hardships at midlife: prediction of long-term stroke mortality.
|
Int J Cardiol
|
2013
|
0.76
|
|
86
|
Long-term versus intermediate-term supervised exercise training in advanced heart failure: effects on exercise tolerance and mortality.
|
Int J Cardiol
|
2006
|
0.76
|
|
87
|
Trombolysis in acute stroke.
|
Isr Med Assoc J
|
2006
|
0.76
|
|
88
|
Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey.
|
J Stroke Cerebrovasc Dis
|
2007
|
0.76
|
|
89
|
Decrease in triglyceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudy.
|
Coron Artery Dis
|
2006
|
0.76
|
|
90
|
Safer thrombolysis for acute ischemic stroke: is early recanalization the key?
|
Neurology
|
2008
|
0.75
|
|
91
|
Stroke: secondary stroke prevention--personalized antiplatelet therapy.
|
Nat Rev Neurol
|
2012
|
0.75
|
|
92
|
Hyperglycemia and early reperfusion therapy.
|
Stroke
|
2003
|
0.75
|
|
93
|
Prestroke treatment with beta-blockers for hypertension is not associated with severity and poor outcome in patients with ischemic stroke: data from a national stroke registry.
|
J Hypertens
|
2016
|
0.75
|
|
94
|
Outcomes of basilar artery occlusion in patients aged 75 years or older in the Basilar Artery International Cooperation Study.
|
J Neurol
|
2012
|
0.75
|
|
95
|
Letter by Kurnik et al regarding article, "antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations".
|
Stroke
|
2013
|
0.75
|
|
96
|
Aortic valve calcium on spiral computed tomography is associated with calcification of the thoracic aorta in hypertensive patients.
|
Am J Cardiol
|
2002
|
0.75
|
|
97
|
Neurological implications of hyperhomocysteinemia in patients with atherothrombotic disease.
|
Ital Heart J
|
2003
|
0.75
|
|
98
|
Is the evaluation and treatment of transient ischemic attack performed according to current knowledge? A nationwide Israeli registry.
|
Isr Med Assoc J
|
2013
|
0.75
|
|
99
|
[Approach to the diagnosis and management of transient ischemic attack in Israel].
|
Harefuah
|
2013
|
0.75
|
|
100
|
Decompressive hemicraniectomy as a lifesaving procedure in severe acute ischemic stroke.
|
Isr Med Assoc J
|
2003
|
0.75
|
|
101
|
Birthplace differences in stroke rates among coronary heart disease patients: is variation explained by recognized risk factors?
|
Isr Med Assoc J
|
2009
|
0.75
|
|
102
|
[Guideliness for the management of stroke--2008 invasive measures for prevention of ischemic stroke].
|
Harefuah
|
2008
|
0.75
|
|
103
|
Association of mitral annular calcium on spiral computed tomography (dual-slice mode) with thoracic aorta calcium in patients with systemic hypertension.
|
Am J Cardiol
|
2002
|
0.75
|
|
104
|
Angina pectoris severity among coronary heart disease patients is associated with subsequent cognitive impairment.
|
Alzheimer Dis Assoc Disord
|
2015
|
0.75
|
|
105
|
Improved exercise tolerance and cardiac function in severe chronic heart failure patients undergoing a supervised exercise program.
|
Int J Cardiol
|
2007
|
0.75
|